David owns an engineering degree in biotechnology.
He has worked for the Institute of Neurosciences in Grenoble before joining NETRIS Pharma in 2013.
As a R&D engineer, David is in charge of the design, set-up and realization of pharmacological studies aiming to evaluate drug candidate anticancer potential.